Neoantigen Expert Roundtable

Oct 13 2022 at Time:12:30 PM EDT

Please join a KOL panel of experts in the neoantigen field to discuss the importance of neoantigens as targets in solid tumor cell therapy. Charles Swanton, MD, PhD, FRS, FRCP (Francis Crick Institute & UCL), John Haanen, MD (Netherlands Cancer Institute), and Christopher Klebanoff, MD (Memorial Sloan Kettering Cancer Center) will participate in an in-depth scientific panel discussion, moderated by LifeSci Partners Managing Director, Neil Canavan.

Print Page
RSS Feeds
Email Alerts
Contact IR